Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
19.99
+0.12 (0.60%)
At close: Mar 28, 2025, 4:00 PM
19.86
-0.13 (-0.65%)
After-hours: Mar 28, 2025, 4:54 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $642.18 million as of March 28, 2025. Its market cap has decreased by -25.24% in one year.
Market Cap
642.18M
Enterprise Value
286.70M
1-Year Change
-25.24%
Ranking
Category
Stock Price
$19.99
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $642.18M, an increase of 293.99%. That is a compound annual growth rate of 143.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 642.18M | -0.47% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |